Aqueous Flare after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Drugs in Neovascular Age-Related Macular Degeneration

Aqueous flare values in patients with neovascular age-related macular degeneration (nAMD) receiving anti-vascular endothelial growth factor (VEGF) therapy, including brolucizumab. This retrospective study included 278 patients (542 eyes) treated with intravitreal anti-VEGF injections at Jichi Medical University Hospital from March to July 2021. Aqueous flare values were measured in both affected and fellow eyes.